AdaptHealth (AHCO) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
The meeting was called to order by the CEO, who welcomed stockholders and explained the virtual format to maximize participation.
Attendees were informed about the opportunity to submit questions during the meeting, with a Q&A session scheduled after formal business.
The record date for voting was April 24, 2026, and proxy materials were distributed on or about April 28, 2026.
Corporate governance
Quorum was established with sufficient shares present or represented by proxy.
Lou Larson was appointed as Inspector of Elections and took an oath of office.
Board and executive committee updates
Nine directors were nominated for election to serve a one-year term expiring at the 2027 annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from AdaptHealth
- Strategic divestitures and operational shifts set the stage for focused growth and margin gains.AHCO
2026 Global Healthcare Conference - Streamlined focus, capitation growth, and tech adoption drive national expansion and efficiency.AHCO
2026 Jefferies Healthcare Services and Technology Conference - Portfolio streamlined to focus on sleep and respiratory, fueling growth and digital innovation.AHCO
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 revenue rose up to 15.9%, but a $144M goodwill impairment drove a net loss.AHCO
Q2 2026 - Major new capitated contract boosts growth, with margins set to improve through 2026.AHCO
Bank of America Global Healthcare Conference 2026 - Net revenue up 5.4% to $819.8M, but margin and net loss worsened amid higher costs.AHCO
Q1 2026 - Q2 2024 net revenue rose 1.6% to $806M, with strong cash flow and 20.5% EBITDA margin.AHCO
Q2 2024 - Q3 2024 saw stable revenue, a return to profitability, and improved free cash flow.AHCO
Q3 2024 - 2024 saw a return to profitability, strong cash flow, and stable margins despite headwinds.AHCO
Q4 2024